Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-03-01 @ 5:19 PM
Study NCT ID:
NCT04419402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2020-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-28
First Submit QC Date:
None
Study First Post Date:
2020-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-06
Last Update Post Date:
2024-02-07
Last Update Post Date Type:
ACTUAL